Popular on Rezul
- Vitanergy Health US Inc. Launches Three New Dietary Supplements to Support Women's Daily Wellness - 177
- Where You Play Matters: MrBet Decodes Europe's Complex Gambling Tax Rules in New Report - 160
- Sanadatum(SDTM) Foundation Launches Revolutionary Health Data Economy Platform - 158
- Genpak Increases Foodservice Packaging Efficiency for Emerging Restaurants - 153
- Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection - 150
- Assent Joins AWS ISV Accelerate Program - 132
- Delirious Comedy Club and House of Magic Open 2nd Location at Silver Sevens Hotel & Casino - Vegas-Quality Shows, Old Vegas Prices - 126
- Vancouver Community College Forms Strategic Partnership with PebblePad - 118
- OddsTrader Asks: What Are the Chances Your Team Makes the NFL Playoffs? - 118
- RUNWAY Milestones 1995-2025 Global Influence - 117
Similar on Rezul
- The Learning Circle Childcare Centre – South Surrey Campus Currently Enrolling for September & Fall
- New Leadership Model – Never Fire Anyone – Released Today
- IOTAP Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
- The Squires Group Becomes a Workday Partner
- 500% Increase in Revenue for Q2 with Acquisition Plans Including UK Telecom 3D Design/Modeling Company for Global AI Drone & Quantum Computing Leader
- K2 Integrity and Rafidain Bank Launch Strategic Partnership to Strengthen Financial Integrity
- Joint Venture for Expansion Into Asset-Backed Real Estate; $100 Million Initiative via Offering of Shares at Over $4 for Digital Assets: $OFAL
BioLab Holdings, Inc. Launches Its Largest Clinical Trial to Date Evaluating Human Placental Membrane Products
Rezul News/10710036
PHOENIX, July 31, 2025 ~ Phoenix-based medical manufacturer, BioLab Holdings, Inc., has announced the launch of its most comprehensive clinical trial to date. The trial, titled "A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (BIOCAMP)," aims to evaluate the effectiveness of four human placental membrane (HPM) products in combination with standard of care (SOC) for treating nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on Rezul News
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on Rezul News
- Silva Construction Discusses the Benefits of Garage Conversions for Growing Families
- Integris Composites Joins Pacific Future Forum in Tokyo
- Titan Pressure Washing Educates Stuart Florida Neighborhoods on Lichen, Algae, and Moss Cleanup
- BusinessRate Selects New Jersey Therapy & Life Coaching as Best Couselors
- DFW Hard Money Rebrands as PBR Capital Partners, Signaling a Broader, Growing CRE Finance Platform
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
Filed Under: Business
0 Comments
Latest on Rezul News
- Lineus Medical and Venture Medical Sign New Zealand Distribution Agreement
- Black Plumbing Expands to Cleburne, TX, Bringing Over 30 Years of Trusted Plumbing Service
- Final Building Release at Collection at Wolf Creek: Great Values to Buy Now with Time to Personal
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
- Phoenix/Scottsdale Real Estate Agent Promotes Homes To MORE Buyers For MORE Money
- New Book: Cold War Sci-Fi Thriller Arrives Today
- BeeCool Bikes Unveils Next-Generation "Super Frame" with Bee Defender Series
- University of South Pacific and Battery Pollution Technologies Forge Strategic Partnership to tackle Battery End-of-Life Challenges in the Pacific
- Shincheonji Tanzania Church Holds Revelation Bible Exam with Local Pastors and Believers
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- Garneau Electric Launches Dedicated Warehouse Electrician Services Across NH & MA
- Growth Acceleration via Strategic Reverse Split After $10 Million Acquisition for Concerts.com and TicketStub.com; AI Powered Sports/Entertainment Co
- OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
- Century Fasteners Corp. Exhibiting at the 2025 International Fastener Expo
- Beware: Criminals Can Steal Your Home Through Fraud and Identity Theft
- Canvas Cloud AI Launches to Transform Cloud Education From Memorization to Mastery
- The Squires Group Becomes a Workday Partner
- From Vernon Hills to Mensa Before Kindergarten
- PermianMuseum.com adds Interstellar Visitor Video Gallery
- SOBREO Elixirs Debut in New York City, Defining a New Era in Inclusive Hospitality